Altimmune ALT
NASDAQ ALT
$1.93 -0.01 (-0.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Altimmune (ALT) Dividends Paid - Common and Preferred (2017)

Updated

Altimmune's Dividends Paid - Common and Prefferd was $200.25 million in Q1 2017.

Analysis

Altimmune (ALT) Dividends Paid - Common and Preferred (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div Paid (Total) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 1.54 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 3.23 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 3.07 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.10 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -8.24 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.04 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.45 Bn
10 Altimmune 377.28 Mn -764.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 200.25 Mn
API Access

Altimmune Dividends Paid - Common and Preferred API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-paid-common-and-prefferd&ticker=ALT&period=max&api_key=YOUR_API_KEY